Hubbard Cristin 5
5 · BIOMARIN PHARMACEUTICAL INC · Filed Feb 13, 2026
Insider Transaction Report
Form 5
Hubbard Cristin
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
[F1]2025-10-31$45.53/sh+80$3,643→ 30,625 total
Footnotes (1)
- [F1]Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact|2026-02-13